Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo

Keyphrases

• T Cells 100%
• Cytotoxic Activity 100%
• Bispecific 100%
• Cell Toxicity 100%
• Human Melanoma 100%
• B7-H3 100%
• Activated T Cells 60%
• Bispecific Antibody 50%
• Melanoma Cells 20%
• Tumor 10%
• Tumor Growth 10%
• Tumor Cells 10%
• Primary Culture 10%
• Luciferase Reporter 10%
• Cytotoxicity 10%
• Melanoma Patients 10%
• Melanoma 10%
• Effector Target 10%
• CD69 Expression 10%
• Bioluminescent 10%
• Xenograft Mouse Model 10%
• Human Melanoma Cells 10%
• CD25 Expression 10%
• Immune Checkpoint 10%
• Melanoma Growth 10%
• T Cell Immunotherapy 10%
• Activating Markers 10%

Medicine and Dentistry

• In Vitro 100%
• T Cell 100%
• Cytotoxic T-Cell 100%
• Melanoma 100%
• Bispecific Antibody 71%
• Melanoma Cell 42%
• Immunotherapy 28%
• Infusion 14%
• Tumor Cell 14%
• Tumor 14%
• Cell Line 14%
• Primary Culture 14%
• Xenograft 14%
• Tumor Progression 14%
• Cytotoxicity 14%
• Luciferase 14%
• Bioluminescence 14%

Immunology and Microbiology

• T Cell 100%
• Cytotoxic T Cell 100%
• In Vitro 100%
• Bispecific Antibody 71%
• Melanoma Cell 42%
• Immunotherapy 28%
• Mouse Model 14%
• Tumor Cell 14%
• Cell Line 14%
• Primary Culture 14%
• Xenograft 14%
• Cytotoxicity 14%
• CD25 14%
• CD69 14%
• Bioluminescence 14%